Brief: Nicox Announces Additional Approval For Vyzulta In Taiwan
09/03/2020 06:38
March 9 (Reuters) - NICOX SA NCOX.PA :
* NICOX SA TODAY ANNOUNCES THAT ITS PARTNER, BAUSCH + LOMB,
HAS
RECEIVED APPROVAL FOR VYZULTA (LATANOPROSTENE BUNOD OPHTHALMIC
SOLUTION), 0.024% IN TAIWAN.
Source text for Eikon: ID:nGNX2SKP7h
Further company coverage: NCOX.PA
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))